Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

207 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Active, not recruiting

Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

NCT05710666

Conditions
HER2-positive Breast Cancer
Locations
  • University Hospital Galway Galway, Connacht, Ireland
  • Saint Vincent's University Hospital Dublin, Leinster, Ireland
  • Beaumont Hospital Dublin, Leinster, Ireland
  • Cork University Hospital Cork, Munster, Ireland
View Trial Details
Completed

To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)

NCT03644186

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • AZ Klina, Augustijinslei 100 Brasschaat, Belgium
  • Jules Bordet Institute Brussels, Belgium
  • CHR de la Citadelle, Boulevard du XIIe de Ligne, 1 Liège, Belgium
  • Clinique Saint- Joseph, Rue de Hesbaye 75 Liège, Belgium
View all 54 locations
View Trial Details
Completed

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

NCT01730833

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope- South Pasadena Cancer Center South Pasadena, California, United States
View Trial Details

Related conditions